• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Histological Growth Patterns of Colorectal Peritoneal Metastases Significantly Affect Prognosis in Patients Presenting for Curative-Intent Cytoreductive Surgery.

作者信息

El Asmar Antoine, Kamdem Leonel, Khaled Charif, Liberale Gabriel

机构信息

Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

出版信息

Ann Surg Oncol. 2024 Jul;31(7):4558-4559. doi: 10.1245/s10434-024-15206-y. Epub 2024 Mar 22.

DOI:10.1245/s10434-024-15206-y
PMID:38519784
Abstract
摘要

相似文献

1
ASO Author Reflections: Histological Growth Patterns of Colorectal Peritoneal Metastases Significantly Affect Prognosis in Patients Presenting for Curative-Intent Cytoreductive Surgery.ASO作者反思：结直肠癌腹膜转移的组织学生长模式对接受根治性减瘤手术患者的预后有显著影响。
Ann Surg Oncol. 2024 Jul;31(7):4558-4559. doi: 10.1245/s10434-024-15206-y. Epub 2024 Mar 22.
2
ASO Author Reflections: Centralization of Cytoreductive Surgery Alone in Colorectal Peritoneal Metastases Patients: Optimizing Treatment Pathways.ASO作者反思：单纯减瘤手术在结直肠癌腹膜转移患者中的集中化：优化治疗路径
Ann Surg Oncol. 2024 Sep;31(9):6274-6275. doi: 10.1245/s10434-024-15463-x. Epub 2024 May 18.
3
ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.ASO作者反思：解决基于医院的孤立性结直肠腹膜转移患者在接受细胞减灭术联合热灌注化疗（CRS-HIPEC）及生存方面的差异问题。
Ann Surg Oncol. 2024 Jun;31(6):3787-3788. doi: 10.1245/s10434-024-15193-0. Epub 2024 Mar 18.
4
ASO Author Reflections: The Timing of Onset of Peritoneal Metastases from Colorectal Carcinoma Is Not an Independent Predictor of Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.ASO作者反思：结直肠癌腹膜转移的发病时间并非是经细胞减灭术联合腹腔内热化疗后生存结局的独立预测因素。
Ann Surg Oncol. 2022 Oct;29(11):6577-6578. doi: 10.1245/s10434-022-11842-4. Epub 2022 Apr 29.
5
ASO Author Reflections: Cytoreductive Surgery for Colorectal Peritoneal Metastases-Is It Time to Audit Our Results?ASO作者反思：结直肠癌腹膜转移的减瘤手术——是时候审视我们的结果了吗？
Ann Surg Oncol. 2022 Jan;29(1):203-204. doi: 10.1245/s10434-021-10701-y. Epub 2021 Aug 25.
6
Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.结直肠腹膜转移的细胞减灭术和腹腔热灌注化疗的演变：8 年单中心经验。
Dis Colon Rectum. 2019 Oct;62(10):1195-1203. doi: 10.1097/DCR.0000000000001456.
7
ASO Author Reflections: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity Score Analysis.ASO作者反思：全身化疗对接受减瘤手术和热灌注化疗（HIPEC）治疗的结直肠癌腹膜转移患者是否有用？一项倾向评分分析。
Ann Surg Oncol. 2024 Mar;31(3):2008-2009. doi: 10.1245/s10434-023-14468-2. Epub 2023 Oct 18.
8
Retrospective Evaluation of the Prognostic Value of Histological Growth Pattern in Patients with Colorectal Peritoneal Metastases Undergoing Curative-Intent Cytoreductive Surgery.回顾性评估有治愈性意图细胞减灭术的结直肠腹膜转移患者组织学生长模式的预后价值。
Ann Surg Oncol. 2024 Jun;31(6):3778-3784. doi: 10.1245/s10434-024-15125-y. Epub 2024 Mar 15.
9
Letter to the Editor "Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases".致编辑的信《术前血清生物标志物对接受根治性减瘤手术治疗结直肠癌腹膜转移患者的预后价值》
Ann Surg Oncol. 2023 Oct;30(11):6775-6776. doi: 10.1245/s10434-023-13917-2. Epub 2023 Jul 15.
10
ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).ASO作者反思：微卫星和RAS/RAF突变状态作为接受减瘤手术和腹腔内热灌注化疗（HIPEC）治疗的结直肠癌腹膜转移的预后因素
Ann Surg Oncol. 2022 Jun;29(6):3418-3419. doi: 10.1245/s10434-021-11057-z. Epub 2021 Nov 6.

本文引用的文献

1
The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study.结直肠癌腹膜转移不同组织学生长模式的预后价值：一项初步研究。
Ann Surg Oncol. 2023 Jun;30(6):3320-3328. doi: 10.1245/s10434-023-13118-x. Epub 2023 Feb 8.
2
ASO Author Reflections: Peritoneal Metastases of Colorectal Origin Exhibit Distinct Histological Growth Patterns with a Potential Prognostic Value.ASO作者反思：结直肠来源的腹膜转移表现出不同的组织学生长模式，具有潜在的预后价值。
Ann Surg Oncol. 2023 Jun;30(6):3329-3330. doi: 10.1245/s10434-023-13172-5. Epub 2023 Feb 3.
3
Galectin-3 Regulates the Expression of Tumor Glycosaminoglycans and Increases the Metastatic Potential of Breast Cancer.
半乳糖凝集素-3调节肿瘤糖胺聚糖的表达并增加乳腺癌的转移潜能。
J Oncol. 2019 Dec 17;2019:9827147. doi: 10.1155/2019/9827147. eCollection 2019.
4
Serious Postoperative Complications Affect Early Recurrence After Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Carcinomatosis.严重术后并发症影响结直肠癌腹膜转移瘤细胞减灭术和腹腔热灌注化疗后的早期复发。
Ann Surg Oncol. 2015 Aug;22(8):2656-62. doi: 10.1245/s10434-014-4297-y. Epub 2014 Dec 17.
5
The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study.奥沙利铂或丝裂霉素 C 在结直肠癌腹膜转移 HIPEC 治疗中的应用：一项对比研究。
J Surg Oncol. 2014 May;109(6):527-32. doi: 10.1002/jso.23546. Epub 2013 Dec 28.